- Original article
- Open Access
The effect of topical vancomycin on the recurrent postoperative sinonasal polyposis: a triple-blinded randomized controlled trial
The Egyptian Journal of Otolaryngology volume 33, pages15–19(2017)
To assess the effect of topical vancomycin on the prevention of recurrent sinonasal polyposis after functional endoscopic sinus surgical procedure.
Design, setting, and participants
A triple-blind, randomized clinical trial of patients aged 18–70 years with sinonasal polyposis whose nasal swab results were positive for Staphylococcus aureus and were candidates for functional endoscopic sinus surgical procedure at Besat Hospital, Hamadan University of Medical Sciences, from September 2014 to September 2015.
Patients were randomly assigned to receive a solution of normal saline including 1 g/l vancomycin or a solution of normal saline alone (placebo). Patients were asked to irrigate their nose with 20ml of the prepared solution three times a day for 8 weeks.
Main outcomes and measure
The recurrent polyposis and reinfection with S. aureus at 2, 4, and 6 months after sinus surgery.
Of 118 patients identified, 35 patients whose nasal swab results were positive for S. aureus remained for analysis, and of those, 18 patients were allocated to the placebo group and 17 to the vancomycin group. There was no statistically significant but clinically important difference in the severity of recurrent postoperative polyposis between the two groups. The recurrence rate of postoperative sinonasal polyposis was clinically different between the two groups, although the difference was not statistically significant. The proportion of reinfection with S. aureus in the second month after surgery was 11/18 (61.1%) in the control group versus 3/17 (17.6%) in the vancomycin group (P=0.015). No significant drug adverse effect was reported by the patients.
Conclusion and relevance
This trial indicated that topical vancomycin is a safe drug with no important adverse effects that may reduce the recurrent postoperative polyposis. However, more evidence based on large clinical trials is required to justify the efficacy of topical vancomycin for preventing postoperative polyposis.
Babbel RW, Harnsberger HR, Sonkens J, Hunt S. Recurring patterns of inflammatory sinonasal disease demonstrated on screening sinus CT. AJNR Am J Neuroradiol 1992; 13:903–912.
Flint P, Haughey B, Lund V, Niparko JK, Robbins T, Regan Thomas J, et al. Cummings otolaryngology: head and neck surgery. 6th ed. Philadelphia, PA: Saunders; 2014.
Bernstein JM, Allen C, Rich G, Dryja D, Bina P, Reiser R, et al. Further observations on the role of Staphylococcus aureus exotoxins and IgE in the pathogenesis of nasal polyposis. Laryngoscope 2011; 121:647–655.
Seiberling KA, Conley DB, Tripathi A, Grammer LC, Shuh L, Haines GK, et al. Superantigens and chronic rhinosinusitis: detection of Staphylococcal exotoxins in nasal polyps. Laryngoscope 2005; 115: 1580–1585.
Nadel DM, Lanza DC, Kennedy DW. Endoscopically guided cultures in chronic sinusitis. Am J Rhinol 1998; 12:233–241.
Seiberling KA, Aruni W, Kim S, Scapa VI, Fletcher H, Church CA. The effect of intraoperative mupirocin irrigation on Staphylococcus aureus within the maxillary sinus. Int Forum Allergy Rhinol 2013; 3:94–98.
Comstock RH 3rd, Lam K, Mikula S. Topical antibiotic therapy of chronic rhinosinusitis. Curr Infect Dis Rep 2010; 12:88–95.
Wei CC, Adappa ND, Cohen NA. Use of topical nasal therapies in the management of chronic rhinosinusitis. Laryngoscope 2013; 123: 2347–2359.
Wynn R, Har-El G. Recurrence rates after endoscopic sinus surgery for massive sinus polyposis. Laryngoscope 2004; 114:811–813.
Badia L, Lund V. Topical corticosteroids in nasal polyposis. Drugs 2001; 61:573–578.
Rudmik L, Schlosser RJ, Smith TL, Soler ZM. Impact of topical nasal steroid therapy on symptoms of nasal polyposis: a meta-analysis. Laryngoscope 2012; 122:1431–1437.
Valera FC, Anselmo-Lima WT. Evaluation of efficacy of topical corticosteroid for the clinical treatment of nasal polyposis: searching for clinical events that may predict response to treatment. Rhinology 2007; 45:59–62.
Karr RM. Chronic rhinosinusitis: potential new use for topical sulfasalazine. J Allergy Clin Immunol Pract 2014; 2:349–350.e1.
Rajiv S, Drilling A, Bassiouni A, James C, Vreugde S, Wormald PJ. Topical colloidal silver as an anti-biofilm agent in a Staphylococcus aureus chronic rhinosinusitis sheep model. Int Forum Allergy Rhinol 2015; 5:283–288.
Wang T, Su J, Feng Y. The effectiveness topical amphotericin B in the management of chronic rhinosinusitis: a meta-analysis. Eur Arch Otorhinolaryngol 2015; 272:1923–1929.
Bonfils P, Escabasse V, Coste A, Gilain L, Louvrier C, Serrano E, et al. Efficacy of tobramycin aerosol in nasal polyposis. Eur Ann Otorhinolaryngol Head Neck Dis 2015; 132:119–123.
Hatton AG, Scott H, Hilton JE. Calcium mupirocin non-aqueous nasal spray for otitis media or for recurrent acute bacterial sinusitis. 2000; US6156792 A. Available at: https://www.google.com/patents/US6156792. [Accessed 9 March 2016]
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
About this article
Cite this article
Jahanshahi, J., Yazdani, J., Hashemian, F. et al. The effect of topical vancomycin on the recurrent postoperative sinonasal polyposis: a triple-blinded randomized controlled trial. Egypt J Otolaryngol 33, 15–19 (2017). https://doi.org/10.4103/1012-5574.199411
- clinical trial
- endoscopic surgery
- nasal polyps